期刊
JOURNAL OF EXPERIMENTAL MEDICINE
卷 214, 期 6, 页码 1643-1653出版社
ROCKEFELLER UNIV PRESS
DOI: 10.1084/jem.20160923
关键词
-
资金
- American Cancer Society [RSG-14-049-01-DMC]
- National Institutes of Health [R01HG007354, R01HG007175, R01ES024992, U01CA200060, U24ES026699, R01HL63736, R01HL55337]
- National Institutes of Health (T32 training grant) [5 T32 CA 9547-29]
Recent studies have established that hematopoietic stem cells (HSCs) are quiescent in homeostatic conditions but undergo extensive cell cycle and expansion upon bone marrow (BM) transplantation or hematopoietic injury. The molecular basis for HSC activation and expansion is not completely understood. In this study, we found that key developmentally critical genes controlling hematopoietic stem and progenitor cell (HSPC) generation were up-regulated in HSPCs upon hematopoietic injury. In particular, we found that the ETS transcription factor Ets variant 2 (Etv2; also known as Er71) was up-regulated by reactive oxygen species in HSPCs and was necessary in a cell-autonomous manner for HSPC expansion and regeneration after BM transplantation and hematopoietic injury. We found c-Kit to be downstream of ETV2. As such, lentiviral c-Kit expression rescued Etv2-deficient HSPC proliferation defects in vitro and in short-term BM transplantation in vivo. These findings demonstrate that Etv2 is an important regulator of hematopoietic regeneration.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据